“The Applicant evaluated the safety of repotrectinib administered orally once daily in 28-day and 91-day GLP-compliant general toxicology studies using rats and cynomolgus monkeys.”
✓ VerifiedFDA multi-discipline review, p. 42Source ↗
Why that species
100% sequence homology of target binding sites with human and similar metabolism
“Rats (Sprague-Dawley) and monkeys (cynomolgus) are considered relevant toxicological species based on 100% sequence homology for the target binding sites and similar metabolism.”
“The Applicant evaluated the safety of repotrectinib administered orally once daily in 28-day and 91-day GLP-compliant general toxicology studies using rats and cynomolgus monkeys.”
✓ VerifiedFDA multi-discipline review, p. 42Source ↗